Aldeyra Therapeutics, Inc. (ALDX)
1.34
-0.12
(-8.22%)
USD |
NASDAQ |
Sep 11, 16:00
1.355
+0.02
(+1.12%)
After-Hours: 20:00
Aldeyra Therapeutics Debt to Equity Ratio : 0.0038 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0038 |
| March 31, 2026 | 0.368 |
| December 31, 2025 | 0.351 |
| September 30, 2025 | 0.3156 |
| June 30, 2025 | 0.2814 |
| March 31, 2025 | 0.2448 |
| December 31, 2024 | 0.2155 |
| September 30, 2024 | 0.1835 |
| June 30, 2024 | 0.1591 |
| March 31, 2024 | 0.1381 |
| December 31, 2023 | 0.1307 |
| September 30, 2023 | 0.1316 |
| June 30, 2023 | 0.1244 |
| March 31, 2023 | 0.1174 |
| December 31, 2022 | 0.1065 |
| September 30, 2022 | 0.0983 |
| June 30, 2022 | 0.0914 |
| March 31, 2022 | 0.0833 |
| December 31, 2021 | 0.0771 |
| September 30, 2021 | 0.0721 |
| June 30, 2021 | 0.0661 |
| March 31, 2021 | 0.1222 |
| December 31, 2020 | 0.2576 |
| September 30, 2020 | 0.217 |
| June 30, 2020 | 0.2828 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3414 |
| December 31, 2019 | 0.3069 |
| September 30, 2019 | 0.2882 |
| June 30, 2019 | 0.0049 |
| March 31, 2019 | 0.0048 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0471 |
| June 30, 2018 | 0.0363 |
| March 31, 2018 | 0.0372 |
| December 31, 2017 | 0.0337 |
| September 30, 2017 | 0.029 |
| June 30, 2017 | 0.0568 |
| March 31, 2017 | 0.0472 |
| December 31, 2016 | 0.0608 |
| September 30, 2016 | 0.051 |
| June 30, 2016 | 0.0441 |
| March 31, 2016 | 0.0631 |
| December 31, 2015 | 0.0518 |
| September 30, 2015 | 0.0446 |
| June 30, 2015 | 0.0403 |
| March 31, 2015 | 0.0913 |
| December 31, 2014 | 0.1994 |
| September 30, 2014 | 0.1502 |
| June 30, 2014 | 0.1246 |
| March 31, 2014 | -1.201 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.012 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 47.54M |
| Total Liabilities (Quarterly) | 9.655M |
| Shareholders Equity (Quarterly) | 37.89M |
| Current Ratio | 4.842 |
| Net Debt Paydown Yield | 2.40% |